[1]
2024. A Matching-Adjusted Indirect Comparison of the Efficacy of Bimekizumab and Guselkumab at 52 weeks for the Treatment of Psoriatic Arthritis. SKIN The Journal of Cutaneous Medicine. 8, 1 (Jan. 2024), s312. DOI:https://doi.org/10.25251/skin.8.supp.312.